CA Patent

CA3141863A1 — Methods and compositions for attenuated anti-viral transfer vector immune response

Assigned to Cartesian Therapeutics Inc · Expires 2020-12-03 · 5y expired

What this patent protects

Provided herein are methods and related compositions or kits for administering viral transfer vectors in combination with synthetic nanocarriers comprising an immunosuppressant and a corticosteroid.

USPTO Abstract

Provided herein are methods and related compositions or kits for administering viral transfer vectors in combination with synthetic nanocarriers comprising an immunosuppressant and a corticosteroid.

Drugs covered by this patent

Patent Metadata

Patent number
CA3141863A1
Jurisdiction
CA
Classification
—
Expires
2020-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Cartesian Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.